Beyond Face Value - Part 2
Media formats available:
Details
Presenters
Overview
When it comes to minimally-invasive facial rejuvenation, what's possible with today's tools? What's expected? What's appropriate? Sachin M. Shridharani, MD and Navin Singh, MD outline principles of facial aesthetics, discuss important anatomical considerations, review data about patient expectations, and outline effective approaches to full-face rejuvenation. This webinar is the second part of a two part series. Supported by a educational grant from Allergan. Learning Objectives
Upon completion of this activity, the participant should be able to: - Describe the properties of different injectable fillers and explain how these properties provide different lifting/filling effects.
- Devise strategies for facial rejuvenation that employ the unique characteristics of different fillers to achieve complementary effects.
- Identify opportunities for combination strategies for rejuvenation that optimize aesthetic outcomes, patient convenience, cost, and satisfaction.
- Describe the potential effects of facial rejuvenation on the patient psyche and discuss possible impact on quality of life.
- Utilize strategies to elicit patient desires and deliver combination approaches to facial rejuvenation that meet patient objectives.
Accreditation
Accreditation Statement Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA Credit Designation Statement Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
The following faculty members have the following financial relationships with commercial interests: Sachin Shridharani, MD and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan plc; Galderma Laboratories L.P.; Merz; and Mira Mar, Inc. Grant/Research Support: Allergan plc.; Galderma Laboratories L.P.; Merz and Mira Mar, Inc. Speaker’s Bureau: Allergan plc; Galderma Laboratories L.P.; and Mira Mar, Inc. Navin Singh, MD and or spouse has had no financial agreements or affiliations during the past year. Editorial Support Disclosure Cheryl Cavanaugh, MS, Evolve Medical Education LLC and Anthony Rossi, Peer Reviewer, have no financial agreements with commercial interests.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, or Allergan. REFERENCES 1 Hancox JG, Venkat AP, Coldiron B, Feldman SR, Williford PM. The safety of office-based surgery: review of recent literature from several disciplines. Arch Dermatol. 2004 Nov;140(11):1379-82. 2 2.Fagien S, Cassuto D. Reconstituted injectable hyaluronic acid: expanded applications in facial aesthetics and additional thoughts on the mechanism of action in cosmetic medicine. Plast Reconstr Surg. 2012 Jul;130(1):208-17. 3 Coleman SR. Avoidance of arterial occlusion from injection of soft tissue fillers. Aesthet Surg J. 2002 Nov;22(6):555-7. 4 Zeichner JA, Cohen JL. Use of blunt tipped cannulas for soft tissue fillers. J Drugs Dermatol. 2012 Jan;11(1):70-2. 5 Fulton J, Caperton C, Weinkle S, Dewandre L. Filler injections with the blunt-tip microcannula. J Drugs Dermatol. 2012 Sep;11(9):1098-103. 6 Hexsel D, Soirefmann M, Porto MD, Siega C, Schilling-Souza J, Brum C. Double-blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds. Dermatol Surg. 2012 Feb;38(2):207-14. 7 Rzany B, Becker-Wegerich P, Bachmann F, Erdmann R, Wollina U. Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use. J Cosmet Dermatol. 2009 Dec;8(4):317-23. 8 Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg. 2006 Sep-Oct;22(5):335-41 9 Hirsch RJ, Brody HJ, Carruthers JD. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid. J Cosmet Laser Ther. 2007 Sep;9(3):182-5. 10 Smith SR, Jones D, Thomas JA, Murphy DK, Beddingfield FC 3rd. Duration of wrinkle correction following repeat treatment with Juvéderm hyaluronic acid fillers. Arch Dermatol Res. 2010 Dec;302(10):757-62. 11 Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg. 2008 Mar;34(3):326-35 12 Luebberding S, Alexiades-Armenakas M. Safety of dermal fillers. J Drugs Dermatol. 2012 Sep;11(9):1053-8. 13 Cohen JL, Dayan SH, Brandt FS, Nelson DB, Axford-Gatley RA, Theisen MJ, Narins RS. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg. 2013 Feb;39(2):205-31. 14 Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg. 2008 Jun;34 Suppl 1:S105-9. 15 Arlette JP, Trotter MJ. Anatomic location of hyaluronic acid filler material injected into nasolabial fold: a histologic study. Dermatol Surg. 2008 Jun;34 Suppl 1:S56-62 16 Dermatol Surg. 2012 Jul;38(7 Pt 2):1162-9. doi: 10.1111/j.1524-4725.2012.02471.x. Superficial dermal injection of hyaluronic acid soft tissue fillers: comparative ultrasound study. Micheels P, Besse S, Flynn TC, Sarazin D, Elbaz Y. 17 Narurkar V, et al. Cosmetic Injectables: Emerging Uses, Techniques, And Data. Practical Dermatology. 2013; 10(6 Supplement). 18 Wollina U. Facial rejuvenation starts in the midface: three-dimensional volumetric facial rejuvenation has beneficial effects on nontreated neighboring esthetic units. J Cosmet Dermatol. 2015 Aug 25 19 Cuerda-Galindo E, Palomar-Gallego MA, Linares-Garcíavaldecasas R. Are combined same-day treatments the future for photorejuvenation? Review of the literature on combined treatments with lasers, intense pulsed light, radiofrequency, botulinum toxin, and fillers for rejuvenation. J Cosmet Laser Ther. 2015 Feb;17(1):49-54. 20 Seery T. Modern Aesthetics May/June 2015. Vol 3., No. 4 21 Dayan SH. Mind, Mood, and Aesthetics Aesthetic Surgery Journal 2015; doi: 10.1093/asj/sjv03 System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!